Fig. 3From: Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysisForest plots of pooled rates for a ORR, and b DCR within subgroups for combination-based treatment administrated to the participantsBack to article page